CIK 0001636282 · Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464312787
- Phone
- 6176515940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +640,000 | 640,000 | ||
| 2022-11-29 | Goldberg Jeff Marc President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,884,838 | 1,884,838 | ||
| 2022-11-14 | Neuman Linda L Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-08-25 | Souza Marcio Director | Purchase | +90,000 | $0.56 | $50K | 90,000 |
| 2022-08-23 | Kastenmayer James Paul Interim CEO & General Counsel | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-08-23 | Sloan Leslie Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-08-23 | Hanley Jr. Michael Conick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-08-23 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-06-08 | Hanley Jr. Michael Conick Chief Commercial Officer | Purchase | +28,200 | $0.71 | $20K | 36,200 |
| 2022-06-07 | Lawton Alison Frances Director | Grant or award · Director Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2022-06-07 | Shanafelt Armen Director | Grant or award · Director Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2022-06-07 | Souza Marcio Director | Grant or award · Director Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2022-06-07 | Smith Hunter C Director | Grant or award · Director Stock Option (right to buy) | +43,000 | 43,000 |
Page 11 of 11 · 213 trades